Summary
As a business strategist who's spent decades guiding entrepreneurs through the maze of taxes, funding, and growth strategies, I've seen firsthand how policy shifts can make or break innovation. The One Big Beautiful Bill Act (OBBB), signed into law on July 4, 2025, is one of those pivotal moments. It reinstates immediate expensing for U.S. research and experimental (R&E) expenditures, undoing the constraints from the 2017 Tax Cuts and Jobs Act (TCJA) that had businesses—especially smaller ones—tied up in knots for years. This legislation isn't just tax jargon; it's a lifeline for companies pushing boundaries in tech, software, and beyond.
As a business strategist who’s spent decades guiding entrepreneurs through the maze of funding, taxes, and growth strategies, I’ve seen firsthand how policy shifts can make or break innovation. The One Big Beautiful Bill Act (OBBB), signed into law on July 4, 2025, is one of those pivotal moments. It reinstates immediate expensing for U.S. research and experimental (R&E) expenditures. It removes the constraints imposed by the 2017 Tax Cuts and Jobs Act (TCJA) that had businesses, especially smaller ones, such as SBIR and STTR recipients. This legislation isn’t just tax jargon; it’s a lifeline for companies pushing boundaries in tech, software, and beyond.
The Key Shifts: What You Need to Know
Let’s break it down practically. In business, time is money, and understanding these changes can have a direct impact on your bottom line and cash flow.
Immediate Expensing Returns for Domestic R&E
Starting with tax years after December 31, 2024, you can fully deduct domestic R&E costs in the year you incur them. The mandatory capitalization is eliminated. You don’t have to amortize over five years, as was the case under the TCJA from 2022 to 2024. This change puts cash back in your pocket sooner, fueling reinvestment in what matters most—your next breakthrough. Whether it’s lab work, prototypes, or software tweaks, as long as it’s U.S.-based, you’re in good shape. I’ve advised countless startups where delayed deductions meant scraping by on fumes; this levels the playing field.
Flexibility with Optional Amortization
Not every business fits a one-size-fits-all mold. That’s why OBBB lets you choose to capitalize and amortize those domestic R&E expenses over their useful life—at least 60 months—or a straight 10-year period. It’s a smart option if your tax strategy involves timing deductions to maximize advantage, such as aligning with revenue spikes or investor expectations.
Foreign R&E Stays the Course
Don’t get too excited if your research spans borders—the 15-year amortization rule for foreign research and experimentation (R&E) remains unchanged. The different treatment of foreign expenditures serves as a clear incentive to keep innovation stateside. From my experience working with global firms, I’ve found that it’s a powerful incentive to rethink where you base your R&D teams.
Software Development Gets Clear Inclusion
High-growth tech and SaaS companies, take note: Software development costs are now explicitly qualified as R&E expenditures. No more gray areas or second-guessing. This clarity is immense for scaling operations without the headache of audits questioning every line of code.
Tailored Relief for Small Businesses
Here’s where it gets personal for the underdogs I love championing—small businesses with average gross receipts of $31 million or less. OBBB includes a rare “catch-up” provision that allows for retroactive immediate expensing for 2022–2024 via amended returns. Think about it: If capitalization rules squeezed your cash flow during those lean years, this is your chance to reclaim deductions and breathe easier. For businesses of all sizes, new transition rules allow you to accelerate any unamortized domestic research and experimentation (R&E) from those periods. Startups and fast-scalers, this could be the boost that turns survival into thriving.
The Bigger Picture: Why This Matters for Growth and Competitiveness
In my years consulting with bio-tech innovators and emerging tech firms, I’ve witnessed how tax policies either spark or stifle progress. OBBB’s R&E overhaul does the former:
- Boosts U.S. Edge: By matching global standards for research incentives, it removes barriers that had been holding American companies back from competing with international rivals.
- Simplifies Operations: Ditch the complex amortization math for most domestic spending, freeing your team to focus on innovation, not spreadsheets.
- Fuels Reinvestment: Immediate cash flow means more resources for R&D scaling, hiring talent, or pivoting to market demands. Small businesses, in particular, gain the agility they’ve been craving.
Navigating the Road Ahead
Expect IRS guidance soon on electing and documenting these provisions, especially the retroactive ones—likely tweaks to Form 3115 and supporting docs. If you’re considering amendments or accelerations, consult your tax advisor now. Don’t wait; opportunities like this reward those who are proactive.
Paired with OBBB’s broader perks, such as enhanced bonus depreciation, this signals a tax landscape that’s finally tilting toward business growth. It’s about empowering domestic research, tech leaps, and economic momentum—exactly what innovators need to lead the charge.
In Essence
The OBBB Act isn’t just legislation; it’s a strategic win for U.S. companies, big and small. It delivers the flexibility, liquidity, and assurance to invest boldly in tomorrow’s innovations. If you’re in the trenches of business building, this could be the catalyst you’ve been waiting for.
References:
- https://tax.thomsonreuters.com/news/re-provisions-in-the-new-tax-act/
- https://www.kirkland.com/publications/kirkland-alert/2025/07/final-one-big-beautiful-bill-act
- https://www.congress.gov/bill/119th-congress/house-bill/1/text
- https://www.dechert.com/knowledge/onpoint/2025/7/tax-reform-2025–the-one-big-beautiful-bill-act-signed-into-law.html
- https://www.cbiz.com/insights/article/senate-passes-its-version-of-one-big-beautiful-bill-act-biggest-impacts
- https://www.anchin.com/articles/one-big-beautiful-bill-act-catalyzes-u-s-research-and-development/
- https://www.crowell.com/en/insights/client-alerts/house-committee-passes-part-of-big-beautiful-bill-containing-noteworthy-improvements-to-research-and-development-incentives-for-companies
- https://www.crfb.org/blogs/breaking-down-one-big-beautiful-bill
- https://www.bracewell.com/resources/big-tax-changes-in-the-one-big-beautiful-bill-act/
- https://www.bdo.com/insights/tax/one-big-beautiful-bill-act-implications-for-accounting-for-income-taxes